News

B4-RNA won Pasaporte Emprendedor 2025

B4-RNA won Pasaporte Emprendedor 2025

B4-RNA was one of the three winning startups of Pasaporte Emprendedor 2025. They had previously been selected—alongside Guska and nine other companies—to receive training sessions with regional mentors. The program concluded with a pitch from each startup, which led B4-RNA to place among the top three winners. Thanks to this, they will gain...

read more
Guska awarded by SantanderX and PwC Uruguay

Guska awarded by SantanderX and PwC Uruguay

Guska received two awards that highlight innovation in Uruguay: the SantanderX Award Uruguay 2025 and the PwC Uruguay Innovation Award 2025. The SantanderX Award seeks to support and elevate the country’s best projects and startups in two categories: "Startup Award" and "University Award". Guska participated in the Startup category. It was...

read more
National Pilot Vaccination Plan Against Cattle Ticks Begins

National Pilot Vaccination Plan Against Cattle Ticks Begins

The National Pilot Vaccination Plan against the cattle tick has officially started. The trial will span seven departments and will support the validation of the vaccine developed by the startup Scaffold Biotech. The plan includes vaccinating more than 4,000 animals across farms in Salto, Artigas, Rivera, Tacuarembó, Treinta y Tres, Cerro Largo,...

read more

Read the second edition of our newsletter here.

(It’s in Spanish, but there’s a translation option at the top right of the menu)

Read the first edition here.

LAB+ in the Media:

Local

Radio Sarandí – Interview with Matías Machado about Scaffold Biotech’s cattle tick vaccine

El País – The five key features of the Uruguayan vaccine that could change the fight against ticks

Radio Sarandí – Carlos Batthyány talks about Lab+, the vaccine developed by Scaffold Biotech, and the drug from Eolo Pharma

InfoNegocios – A Uruguayan startup dedicated to early cancer diagnosis adds a former dLocal member as CEO

Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo

Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse

En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’

Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio

En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer

La Diaria – What do the first four start-ups of the LAB+ seek to develop?

Telemundo  (Channel 12) – Scaffold Biotech: more efficient vaccines for animals

En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska

Subrayado (Channel 10) – LAB+ closed its first financing cycle

Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+

La Diaria – Conversations with the first four biotech start-ups funded by LAB+

El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups

Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups

Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA

Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups

El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?

Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative

Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies